Can we evaluate the cost-effectiveness of personalized medicine?
Personalized medicine, the tailoring of care based on individual characteristics, has grown rapidly in recent years, particularly for cancer treatment.
Personalized medicine, the tailoring of care based on individual characteristics, has grown rapidly in recent years, particularly for cancer treatment.
It is well known that high consumption of antibiotics, and their inappropriate usage for viral infections rather than bacterial ones, leads to resistance to the drugs.
Worldwide, musculoskeletal disorders, such as sprains, fractures and dislocations, are a major cause of sickness absence, work disability, reduced productivity, and early retirement. Musculoskeletal disorders are the most prevalent of all chronic conditions in Canada, and account for almost $15 billion in disability costs.
Data access has been approved for a University of British Columbia project to examine the impact of Choosing Wisely Canada’s recommendations on the overuse and inappropriate use of prescription drugs in British Columbia.
Data access has been approved for a research project aiming to create a personalized risk/benefit assessment tool for patients with stable coronary artery disease, that will help to incorporate both clinician and patient preferences in their treatment.
Data access has been approved for a project aiming to identify gaps in the care of patients who experience an out-of-hospital cardiac arrest, in order to improve long-term health outcomes.
Data access has been approved for a project to determine if payment of the “Specialist Discharge Care Plan for Complex Patient” fee code improved patient outcomes. The research will also evaluate the cost-effectiveness of the fee code as a policy intervention.
Diagnosing disease and monitoring women’s health during pregnancy requires the accurate interpretation of laboratory test results. Interpretation is done by comparing results to a reference interval – the range of values expected in a representative healthy population.
Data access has been approved for a project which will compare disparities in mortality across British Columbia to identify whether there is an level of residential density above which mortality rates increase.
Colorectal cancer (CRC), the third most commonly diagnosed cancer in Canada, is a significant cause of morbidity and mortality and a substantial financial burden on the healthcare system.
Copyright 2025 | All rights reserved